Christopher B. Prentiss, Chief Financial Officer at Adamas Pharmaceuticals Inc (ADMS), sold 3,821 shares at $6.36 ($24K) on 2021-02-01, disclosed to the SEC on 2021-02-01.
Open-market sale of $24k ADMS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ADMS | SELL | 2020-11-02 | $7K | — | Filing → |
| ADMS | SELL | 2020-01-23 | $8K | — | Filing → |
| ADMS | SELL | 2019-07-23 | $6K | — | Filing → |